IL102521A - Decahydro-12-sulfonyl-8h-isoquino [2,1-g] [1,6] naphthyridine and decahydro-11-sulfonyl-benzo [a] pyrrolo [2,3-e] quinolizine derivatives their preparation and pharmaceutical compositions containing them - Google Patents

Decahydro-12-sulfonyl-8h-isoquino [2,1-g] [1,6] naphthyridine and decahydro-11-sulfonyl-benzo [a] pyrrolo [2,3-e] quinolizine derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL102521A
IL102521A IL10252192A IL10252192A IL102521A IL 102521 A IL102521 A IL 102521A IL 10252192 A IL10252192 A IL 10252192A IL 10252192 A IL10252192 A IL 10252192A IL 102521 A IL102521 A IL 102521A
Authority
IL
Israel
Prior art keywords
pyrrolo
llaa
decahydro
naphthyridine
decahydrobenzo
Prior art date
Application number
IL10252192A
Other languages
English (en)
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of IL102521A publication Critical patent/IL102521A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL10252192A 1991-07-17 1992-07-16 Decahydro-12-sulfonyl-8h-isoquino [2,1-g] [1,6] naphthyridine and decahydro-11-sulfonyl-benzo [a] pyrrolo [2,3-e] quinolizine derivatives their preparation and pharmaceutical compositions containing them IL102521A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73169191A 1991-07-17 1991-07-17

Publications (1)

Publication Number Publication Date
IL102521A true IL102521A (en) 1996-05-14

Family

ID=24940584

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10252192A IL102521A (en) 1991-07-17 1992-07-16 Decahydro-12-sulfonyl-8h-isoquino [2,1-g] [1,6] naphthyridine and decahydro-11-sulfonyl-benzo [a] pyrrolo [2,3-e] quinolizine derivatives their preparation and pharmaceutical compositions containing them

Country Status (14)

Country Link
EP (1) EP0524004A1 (esLanguage)
JP (1) JPH0665242A (esLanguage)
KR (1) KR930002346A (esLanguage)
AU (1) AU655998B2 (esLanguage)
CA (1) CA2074038A1 (esLanguage)
FI (1) FI923267L (esLanguage)
HU (2) HUT61550A (esLanguage)
IE (1) IE922314A1 (esLanguage)
IL (1) IL102521A (esLanguage)
IT (1) IT1256880B (esLanguage)
NO (1) NO922812L (esLanguage)
NZ (1) NZ243586A (esLanguage)
TW (1) TW209219B (esLanguage)
ZA (1) ZA925324B (esLanguage)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0411509A (pt) 2003-06-20 2006-07-25 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para tratamento e/ou profilaxia de enfermidades que estão associadas com dpp-iv e sua utilização
CN103387583B (zh) 2012-05-09 2018-04-13 中国科学院上海药物研究所 二芳基并[a,g]喹嗪类化合物、其制备方法、药物组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791108A (en) * 1987-04-13 1988-12-13 Syntex (U.S.A.) Inc. Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers

Also Published As

Publication number Publication date
ITTO920606A0 (it) 1992-07-16
ZA925324B (en) 1994-07-17
ITTO920606A1 (it) 1994-01-16
HUT61550A (en) 1993-01-28
CA2074038A1 (en) 1993-01-18
FI923267A7 (fi) 1993-01-18
NO922812D0 (no) 1992-07-16
AU2031392A (en) 1993-01-21
AU655998B2 (en) 1995-01-19
FI923267L (fi) 1993-01-18
TW209219B (esLanguage) 1993-07-11
IE922314A1 (en) 1993-01-27
FI923267A0 (fi) 1992-07-16
KR930002346A (ko) 1993-02-23
HU9202333D0 (en) 1992-10-28
JPH0665242A (ja) 1994-03-08
NO922812L (no) 1993-01-18
IT1256880B (it) 1995-12-27
EP0524004A1 (en) 1993-01-20
NZ243586A (en) 1995-03-28
HU210711A9 (en) 1995-06-28

Similar Documents

Publication Publication Date Title
US5011846A (en) Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
US4349549A (en) Anti-hypertensive 1-substituted spiro(piperidine-oxobenzoxazine)s
NZ225421A (en) 8,9-annelated-1,2,3,4-tetrahydro-beta-carboline derivatives, preparations thereof and pharmaceutical compositions
EP0943613A1 (en) Oxygenic heterocyclic compounds
EA004500B1 (ru) Антигистаминные спиросоединения
US4710504A (en) Anti-depressant spiro hexahydro arylquinolizine derivatives, composition, and method of use therefor
EP0104632A2 (en) 1'-(3-(1,2-Benzisoxazol-3-yl)propyl)spiro-(benzofuran-2-(3H),3' or 4'-piperidine or 3'-pyrrolidines), a process for their preparation and their use as medicaments
CA1331459C (en) Sulfonyldecahydro-8h-isoquino-¬2,1-g|¬1,6|- naphthyridines, optical isomers thereof and related compounds
IL102521A (en) Decahydro-12-sulfonyl-8h-isoquino [2,1-g] [1,6] naphthyridine and decahydro-11-sulfonyl-benzo [a] pyrrolo [2,3-e] quinolizine derivatives their preparation and pharmaceutical compositions containing them
US5229387A (en) Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives
HU197745B (en) Process for producing pyrido/2,3-b//1,4/benzodiazepinon derivatives and pharmaceutical compositions containing them as active components
AU630085B2 (en) 4,5,6,7-tetrahydro isothiazolo (4,5-c) pyridine derivatives
EP0607163B1 (en) NEUROLEPTIC 2-SUBSTITUTED PERHYDRO-1-H-PYRIDO[1,2-a]PYRAZINES
US3914235A (en) Processes and intermediates for quinine, quinidine, isomers and derivatives thereof
HU203887B (en) Process for producing new condensed diazepinones andpharmaceutical compositions contining them
EP0329932B1 (en) Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments
US4886798A (en) Optical isomers of sulfonyldecahydro-8H-isoquino-(2,1-G)(1,6) naphthyridines and related compounds useful as α2 -blockers
US4956365A (en) Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds
HU208137B (en) Process for producing condensed diazepinone derivatives and pharmaceutical compositions comprising same
US3872129A (en) Processes and intermediates for quinine, quinidine, isomers and derivatives thereof
KR820000095B1 (ko) 트랜스-2-치환된-5-아릴-2,3,4,4a,5,9b-헥사하이드로-1H-피리도[4,3-b]인돌 유도체의 제조방법.
JPWO1998022455A1 (ja) 含酸素複素環化合物

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void